Teva Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Teva Pharma (TEVA) Reports In-Line Q1 EPS; Narrows Guidance
May 3, 2022 7:08 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.55, in-line with the analyst estimate of $0.55. Revenue for the quarter came in at $3.7 billion versus the consensus estimate of $3.74 billion.
GUIDANCE:
Teva Pharma sees FY2022 EPS of $2.40-$2.60, versus the consensus of $2.51.... More
